Topic:
Updates in Immunotherapy for Urologic Malignancies

Abstract:
Evading immune recognition is a major hallmark of cancer, and strategies that can overcome this blockade and allow immune cells to recognize and eliminate cancer cells have begun to show impressive clinical results. In urologic cancers immune therapies are approved for prostate, bladder, and renal cancers, including autologous vaccines and inhibitors targeting the PD-1 and PD-L1 immunologic checkpoints, and multiple trials are underway. Major challenges facing the field include identifying why some patients respond to immunotherapy and others don't, establishing the optimal duration of therapy, understanding the phenomenon of pseudoprogression, and evaluating combination therapies. This talk will provide an update on the current clinical use of immunotherapies in urologic malignancies and discuss directions for the future.

Speaker:

Terence Friedlander, MD

Our speaker will be Terry Friedlander, MD, Assistant Clinical Professor, Hematology/Oncology at the University of California, San Francisco. Dr. Friedlander is a clinical and translational oncologist specializing in cancers of the genitourinary tract, specifically bladder and prostate cancers. His research is focused on understanding the basic biology of these malignancies and in developing novel therapeutic ways to treat disease. As a clinical academic oncologist, Dr. Friedlander serves as principle investigator or coinvestigator on a number of clinical trials in advanced prostate and bladder cancer, which allows his team to recruit patients for much of their biomarker work. He hopes that through his work it will help to predict which patients will respond to differing chemotherapies and be able to tailor clinical strategies that will give the most benefit.

This event will be held in the ASPEN room.

Agenda:
12:00-12:30 - Check-in and lunch

12:30-12:45 - Dylan Daniel, PhD, Director, Scientific Development - Welcome & Introduction

12:45-1:15 - Terry Friedlander, MD - Updates in Immunotherapy for Urologic Malignancies

1:15-1:30 - Q&A

1:30-2:00 - Wrap up discussion

Registrations are closed

Lunch & Learn San Francisco - June 2017